Search Results - "Herrmann, Kirsten H"

Increasing Physical Activity for the Treatment of Hypertension: A Systematic Review and Meta-Analysis by Semlitsch, Thomas, Jeitler, Klaus, Hemkens, Lars G., Horvath, Karl, Nagele, Eva, Schuermann, Christoph, Pignitter, Nicole, Herrmann, Kirsten H., Waffenschmidt, Siw, Siebenhofer, Andrea

“…Background Low physical activity has been identified as a major risk factor for cardiovascular disease. Medical societies therefore recommend increased…”
Get full text

Cost and Clinical Benefits Associated with Oncotype DX® Test in Patients with Early-Stage HR+/HER2- Node-Negative Breast Cancer in the Netherlands by de Jongh, Felix E., Efe, Reva, Herrmann, Kirsten H., Spoorendonk, Jelle A.

“…Objectives. Patients with early-stage HR+/HER2- N0 breast cancer may receive adjuvant chemotherapy in combination with surgery. However, chemotherapy does not…”
Get full text

All nations depend on the global knowledge pool--analysis of country of origin of studies used for health technology assessments in Germany by Herrmann, Kirsten H, Wolff, Robert, Scheibler, Fueloep, Waffenschmidt, Siw, Hemkens, Lars G, Sauerland, Stefan, Antes, Gerd

“…Health Technology Assessments (HTAs) are used to inform decision-making and their usefulness depends on the quality and relevance of research and specific…”
Get full text

Questioning Conclusions and Statements on the German HTA System: A Critical Perspective by Tomeczkowski, Jörg, Heidbrede, Tanja, Leverkus, Friedhelm, Schmitter, Sarah, Dintsios, Charalabos-Markos, Osowski, Ulrike, Herrmann, Kirsten H, Bluhmki, Tobias, Marx, Almuth, Eichinger, Birte, Basic, Edin, Bussilliat, Paul, Dietrich, Eva Susanne

Get full text

GRADE guidance 23: considering cost-effectiveness evidence in moving from evidence to health-related recommendations by Xie, Feng, Shemilt, Ian, Vale, Luke, Ruiz, Francis, Drummond, Michael F., Lord, Joanne, Herrmann, Kirsten H., Rojas, María Ximena, Zhang, Yuan, Canelo-Aybar, Carlos, Alonso-Coello, Pablo, Shamliyan, Tatyana, Schünemann, Holger J.

“…This is the 23rd in a series of articles describing the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to grading the…”
Get full text

Clinical effectiveness of stress-reduction techniques in patients with hypertension: systematic review and meta-analysis by Nagele, Eva, Jeitler, Klaus, Horvath, Karl, Semlitsch, Thomas, Posch, Nicole, Herrmann, Kirsten H, Grouven, Ulrich, Hermanns, Tatjana, Hemkens, Lars G, Siebenhofer, Andrea

“…OBJECTIVE:A systematic review and meta-analysis focusing on patient-relevant outcomes and blood pressure was conducted to assess the clinical effectiveness of…”
Get full text

Cost-effectiveness of early treatment of ACPA-positive rheumatoid arthritis patients with abatacept by Neubauer, Aljoscha S, Minartz, Christof, Herrmann, Kirsten H, Baerwald, Christoph G O

“…Studies have reported that the presence of elevated anti-citrullinated protein antibodies (ACPA)/RF levels, together with joint erosions, is associated with…”
Get full text

Real world data in health technology assessments in kidney transplants in Germany: use of routinely collected data to address epidemiologic questions in kidney transplants in the AMNOG process in Germany by Herrmann, Kirsten H, Meier-Kriesche, Ulf, Neubauer, Aljoscha S

“…It is discussed whether real world data can be used in health technology assessment. Following it is of interest whether routinely collected data for quality…”
Get full text

Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada by Weijers, Laure, Baerwald, Christoph, Mennini, Francesco S., Rodríguez-Heredia, José M., Bergman, Martin J., Choquette, Denis, Herrmann, Kirsten H., Attinà, Giulia, Nappi, Carmela, Merino, Silvia Jimenez, Patel, Chad, Mtibaa, Mondher, Foo, Jason

“…Rheumatoid arthritis (RA) is a chronic inflammatory disorder leading to disability and reduced quality of life. Effective treatment with biologic DMARDs poses…”
Get full text

220 Cost per response for abatacept versus adalimumab in patients with seropositive erosive, early rheumatoid arthritis in the United States, Germany, Spain and Canada by Foo, Jason, Rodríguez-Heredia, José M R, Polanco Sánchez, Carlos, Mtibaa, Mondher, Herrmann, Kirsten H, Alemao, Evo, Postema, Roelien, Baerwald, Christoph

Get full text

HTA und aktuelle Herausforderungen: Harmonisierung, Real World Data und Surrogatparameter by Rüther, Alric, Herrmann, Kirsten H., Hebborn, Ansgar, Perleth, Matthias, Schwarzer, Ruth, Schürmann, Christoph, Sieben, Wiebke, Gillhaus, Johanna, Goertz, Ralf, Jeratsch, Ulli, Leverkus, Friedhelm, Schramm, Wendelin

“…Health Technology Assessment is one of the standard instruments in support of the decision-making to define the public health services both internationally and…”
Get full text

All Nations Depend on the Global Knowledge Pool - Analysis of Country of Origin of Studies Used for Health Technology Assessments in Germany. e59213 by Herrmann, Kirsten H, Wolff, Robert, Scheibler, Fueloep, Waffenschmidt, Siw, Hemkens, Lars G, Sauerland, Stefan, Antes, Gerd

“…Background Health Technology Assessments (HTAs) are used to inform decision-making and their usefulness depends on the quality and relevance of research and…”
Get full text